Board Change • May 27
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Non-Executive Director Greg Kennish was the last independent director to join the board, commencing their role in 2025. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Board Change • May 20
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Non-Executive Director Greg Kennish was the last independent director to join the board, commencing their role in 2025. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. お知らせ • Apr 24
Talius Group Limited, Annual General Meeting, May 28, 2026 Talius Group Limited, Annual General Meeting, May 28, 2026. Location: physically at the offices of bdo, level 18, 360 queen street, brisbane, qld 4000 Australia お知らせ • Nov 08
Talius Group Limited has completed a Follow-on Equity Offering in the amount of AUD 4 million. Talius Group Limited has completed a Follow-on Equity Offering in the amount of AUD 4 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 50,000,000
Price\Range: AUD 0.08
Discount Per Security: AUD 0.0048
Transaction Features: Subsequent Direct Listing お知らせ • Oct 27
Talius Group Limited has filed a Follow-on Equity Offering in the amount of AUD 4 million. Talius Group Limited has filed a Follow-on Equity Offering in the amount of AUD 4 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 50,000,000
Price\Range: AUD 0.08
Discount Per Security: AUD 0.0048
Transaction Features: Subsequent Direct Listing お知らせ • Apr 03
Talius Group Limited, Annual General Meeting, May 22, 2025 Talius Group Limited, Annual General Meeting, May 22, 2025. Location: at the office of bdo, level 10, 12 creek steet, brisbane Australia お知らせ • Apr 02
Talius Group Limited Announces Board and Committee Changes Talius Group Limited announced some key changes to the Board of Directors to ensure a strong and aligned composition for the future growth of the Company. Mr. Stephen Norris has been appointed to the Board as a Non-Executive Director. Mr. Norris has vast experience in the Aged Care Sector and has aligned interests in the success of Talius, given his recent strategic investment in December 2024. The company announced the appointment of Mr. Greg Kennish as a Non-Executive Director. Mr. Kennish brings a wealth of international experience and a deep understanding of technology platforms, including (but not limited to) SaaS models. Mr. Kennish has previously cofounded and led software companies in Asia and Australia, including an ASX listed technology provider. Mr. Kennish will also be appointed as Chair of the Audit & Risk Committee. The Company announced that Mr. Leylan Neep has decided to step down from his role as Director and Chair of the Board, effective immediately. Mr. Ramsay Carter, Non-Executive Director, has agreed to take up the Board Chair role with immediate effect and will also Chair the Nomination & Remuneration Committee. Mr. Neep has served as Chair since September 2020 and overseen the repositioning of Talius from its legacy Homestay Care to its current position as a leading provider of technology-enabled solutions. The Board expresses its gratitude to Mr. Neep for his commitment and stewardship during his tenure as Chair. Mr. Carter has been a Non-Executive Director of the Company since June 2020 and has been a key driver of Talius’ governance and strategy during that time. His knowledge of the Company, the Executive and shareholders provides for a seamless transition of the Chair role. お知らせ • Jan 29
Talius Group Limited Announces Resignation of Marguerite Frances Haertsch as Executive Director, Effective 28 January 2025 Talius Group Limited advised that Dr. Marguerite Frances Haertsch has resigned from her role as Executive Director of the Company to pursue other opportunities. Dr. Haertsch was initially engaged as a consultant in April 2023 to assist Talius in advancing its strategic initiatives and was subsequently appointed as Executive Director of the Company on 15 August 2024. Date of last notice is 17 January 2025. Date that director ceased to be director is 28 January 2025. お知らせ • Dec 31
Talius Group Limited has completed a Follow-on Equity Offering in the amount of AUD 2.57445 million. Talius Group Limited has completed a Follow-on Equity Offering in the amount of AUD 2.57445 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 286,050,000
Price\Range: AUD 0.009
Transaction Features: Subsequent Direct Listing お知らせ • Dec 25
Talius Group Limited has filed a Follow-on Equity Offering in the amount of AUD 2.57445 million. Talius Group Limited has filed a Follow-on Equity Offering in the amount of AUD 2.57445 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 286,050,000
Price\Range: AUD 0.009
Transaction Features: Subsequent Direct Listing Board Change • Dec 24
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 1 independent director (2 non-independent directors). Independent Director Ramsay Carter was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. New Risk • Aug 31
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$1.8m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$1.8m free cash flow). Share price has been highly volatile over the past 3 months (21% average weekly change). Minor Risks Shareholders have been diluted in the past year (13% increase in shares outstanding). Market cap is less than US$100m (AU$18.0m market cap, or US$12.2m). お知らせ • Aug 15
Talius Group Limited Appoints Dr. Maggie Haertsch as Executive Director Talius Group Limited announced the appointment of Dr. Maggie Haertsch to its Board of Directors as an Executive Director, effective immediately. Dr. Haertsch, a seasoned expert in the aged care industry, has been with Talius since March 2023, serving as the Consulting Clinical Research Director. During her tenure, she has been instrumental in advancing Talius' strategic initiatives, including forging alliances with industry bodies, successfully managing the ARIIA Grant project, and refining the Company's strategy across the residential aged care and home care sectors. In her new role, Dr. Haertsch will continue to report to Managing Director Graham Russell while expanding her responsibilities within the Board. With over 40 years of experience in the health and aged care sectors, both in Australia and internationally, Dr. Haertsch brings a wealth of knowledge and a diverse skill set to the Talius Board. Her extensive career spans clinical practice in tertiary teaching hospitals, acute care services, community settings, and low-tech environments, complemented by significant leadership roles in research, education, and executive management. Dr. Haertsch is exceptionally qualified to contribute to Talius' mission in the aged care sector. She holds a PhD in Behavioral Sciences in Medicine, has completed the Leadership in Digital Transformation in Healthcare program at Harvard Medical School, and possesses a Post-Graduate Diploma in Health Science (Primary Health Care) from the Faculty of Health Sciences from the University of Newcastle. In addition, she is a Registered Nurse and was previously a Registered Midwife. お知らせ • Apr 03
Talius Group Limited, Annual General Meeting, May 23, 2024 Talius Group Limited, Annual General Meeting, May 23, 2024, at 10:30 E. Australia Standard Time. Reported Earnings • Feb 29
Full year 2023 earnings released: AU$0.001 loss per share (vs AU$0.001 loss in FY 2022) Full year 2023 results: AU$0.001 loss per share (in line with FY 2022). Revenue: AU$12.4m (up 73% from FY 2022). Net loss: AU$1.34m (loss narrowed 17% from FY 2022). Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has fallen by 21% per year, which means it is significantly lagging earnings. Board Change • Jan 25
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Member of Advisory Board Martin Robinson was the last director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. お知らせ • Dec 08
Talius Group Limited has filed a Follow-on Equity Offering in the amount of AUD 2.5 million. Talius Group Limited has filed a Follow-on Equity Offering in the amount of AUD 2.5 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 277,777,778
Price\Range: AUD 0.009
Transaction Features: Subsequent Direct Listing Board Change • Apr 17
No independent directors There are 4 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 4 new directors. 1 experienced director. No highly experienced directors. No independent directors (3 non-independent directors). MD & Director Graham Russell is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors. Reported Earnings • Mar 03
Full year 2022 earnings released: AU$0.001 loss per share (vs AU$0.001 loss in FY 2021) Full year 2022 results: AU$0.001 loss per share (in line with FY 2021). Revenue: AU$7.20m (up 99% from FY 2021). Net loss: AU$1.62m (loss narrowed 21% from FY 2021). Over the last 3 years on average, earnings per share has increased by 69% per year but the company’s share price has only increased by 36% per year, which means it is significantly lagging earnings growth. Board Change • Nov 16
No independent directors There are 5 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 5 new directors. No experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). MD & Director Graham Russell is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of board continuity. Lack of experienced directors. Recent Insider Transactions • Jun 07
Non-Executive Director recently bought AU$60k worth of stock On the 1st of June, Ramsay Carter bought around 5m shares on-market at roughly AU$0.012 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought AU$864k more in shares than they have sold in the last 12 months. Board Change • Apr 27
No independent directors There are 5 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 5 new directors. No experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). MD & Director Graham Russell is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of board continuity. Lack of experienced directors. Reported Earnings • Mar 02
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Full year 2021 results: AU$0.001 loss per share (vs AU$0.001 loss in FY 2020). Revenue: AU$3.62m (up 17% from FY 2020). Net loss: AU$2.07m (loss narrowed 13% from FY 2020). Revenue was in line with analyst estimates. Recent Insider Transactions • Oct 22
Insider recently bought AU$714k worth of stock On the 19th of October, Kyle Haynes bought around 42m shares on-market at roughly AU$0.017 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought AU$791k more in shares than they have sold in the last 12 months. Recent Insider Transactions • May 08
Non-Executive Chairman recently bought AU$51k worth of stock On the 7th of May, Leylan Neep bought around 3m shares on-market at roughly AU$0.017 per share. This was the largest purchase by an insider in the last 3 months. This was Leylan's only on-market trade for the last 12 months. Executive Departure • Apr 27
CFO & Joint Company Secretary has left the company On the 19th of April, Marcus Fraumano's tenure in the role of CFO & Joint Company Secretary ended. We don't have any record of a personal shareholding under Marcus' name. A total of 4 executives have left over the last 12 months. Reported Earnings • Feb 28
Full year 2020 earnings released: AU$0.001 loss per share (vs AU$0.005 loss in FY 2019) The company reported a solid full year result with reduced losses, improved revenues and improved control over expenses. Full year 2020 results: Revenue: AU$3.11m (up 170% from FY 2019). Net loss: AU$2.37m (loss narrowed 46% from FY 2019).